ID: ALA5275794

Max Phase: Preclinical

Molecular Formula: C12H10FNO2S2

Molecular Weight: 283.35

Associated Items:

Representations

Canonical SMILES:  O=C(O)Cc1csc(SCc2ccc(F)cc2)n1

Standard InChI:  InChI=1S/C12H10FNO2S2/c13-9-3-1-8(2-4-9)6-17-12-14-10(7-18-12)5-11(15)16/h1-4,7H,5-6H2,(H,15,16)

Standard InChI Key:  RTTFSAIGPOQECY-UHFFFAOYSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 283.35Molecular Weight (Monoisotopic): 283.0137AlogP: 3.20#Rotatable Bonds: 5
Polar Surface Area: 50.19Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.69CX Basic pKa: 1.05CX LogP: 3.73CX LogD: 0.42
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.86Np Likeness Score: -2.32

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source